[Platelet aggregation inhibiting treatment with aspirin. Biological bases. Application to cerebral vascular accidents].
D000244:Adenosine Diphosphate / Q000097:blood; D000328:Adult; D001241:Aspirin / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000188:drug therapy*; D001780:Blood Coagulation Tests; D001791:Blood Platelet Disorders / Q000188:drug therapy*; D001792:Blood Platelets / Q000187:drug effects; D002449:Cell Aggregation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy; D002546:Ischemic Attack, Transient / Q000188:drug therapy; D010973:Platelet Adhesiveness / Q000187:drug effects
D000244:Adenosine Diphosphate; D001241:Aspirin
Traitement anti-agrégant plaquettaire par l'aspirine. Bases biologiques. Applications aux accidents vasculaires cérébraux.